Top-Rated Biotech Surges On A Bullish Win In Cancer - Investor's Business Daily

Last Updated: 25.06.2025 17:07

Exelixis (EXEL) stock surged Monday after the biotech company said its next-generation cancer drug showed promise in a study of patients with hard-to-treat colon cancer.

The company tested a combina… [+3212 chars]

Read also:

Trump tariffs expected to dampen global economic growth, OECD says - The Washington Post
Psychopathic individuals recognize unfairness but are less likely to punish it - PsyPost
Yes, You Can Change Outfits In Nightreign , But Not At First - Kotaku
Why do wives cheat on their loyal husbands?
China accuses US of ‘severely violating’ trade truce - Financial Times
Where you live may affect your risk of dementia, UCSF study finds - San Francisco Chronicle
AI Cracks Mars Mystery: 500,000 Streaks Solved Without a Drop of Water - SciTechDaily
‘Dirty Dozen’ 2025: The 12 Most Contaminated Fruits and Vegetables - Food & Wine
I have genetic eyebags and smile lines, but is there any way to get rid of them naturally with some massages or face yoga?
Eric Dane Shares Update on His ALS Diagnosis - The Cut
Study Warns: Carbon Dioxide Removal Methods Could Trigger Ocean Oxygen Crisis - Indian Defence Review